Training in Genomics and Hemoglobinopathies

The summary for the Training in Genomics and Hemoglobinopathies grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Training in Genomics and Hemoglobinopathies: The purpose of this RFA is to train the next generation of researchers who will utilize genomic and proteomic technologies to facilitate the understanding of the biology of hemoglobinopathies in order to prevent the disease and/or to develop effective therapeutic interventions. - The total amount available for this award is approximately 0.7 million dollars. - The anticipated number of awards is between two and three. - The T90 mechanism will be used. - Applicant institutions are limited to U.S. domestic institutions. Foreign institutions that are considered low- and middle-income by World Bank Standards are not eligible to apply, but may be considered as collaborators on the program. - The initiative requires co-program directorsone from each of the relevant disciplines or research areas (hemoglobinopathies and large-scale genomics and proteomics). - The number of applications that each applicant institution may submit is one. - Application materials may be obtained at URL http://grants.nih.gov/grants/funding/phs398/phs398.html. - Telecommunications for the hearing impaired is available at: TTY 301-451-0088